Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor

Danijela Lucic1, Zhi Hua Huang, De Sheng Gu

  • 1Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.

Journal of Lipid Research
|November 3, 2006
PubMed

Insights

Simvastatin treatment and increased LDL receptor expression reduce apolipoprotein E (apoE) secretion by macrophages. This regulation is isoform-specific, impacting lipid flux and potentially atherosclerosis.

Area of Science:

  • Cell Biology
  • Cardiovascular Science
  • Metabolic Research

Background:

  • Apolipoprotein E (apoE) secretion by macrophages influences lipid metabolism and atherosclerosis.
  • Macrophage LDL receptor expression may affect net apoE secretion.

Purpose of the Study:

  • To investigate the regulatory interaction between LDL receptor activity and apoE secretion in macrophages.
  • To determine if modulating LDL receptor expression impacts apoE secretion and cholesterol efflux.

Main Methods:

  • Treatment of J774 macrophages with simvastatin to increase LDL receptor activity.
  • Isolation of mouse peritoneal macrophages (MPMs) from mice with varying LDL receptor expression levels.
  • Analysis of apoE secretion and apoE-mediated cholesterol efflux in response to LDL receptor modulation.

Main Results:

  • Simvastatin treatment reduced apoE secretion in transfected macrophages.
  • Macrophages with increased LDL receptor expression exhibited reduced apoE secretion.
  • The reduction in apoE secretion was isoform-specific (apoE4 > apoE3 > apoE2), correlating with LDL receptor binding affinity.
  • LDL receptor modulation affected apoE-mediated cholesterol efflux.

Conclusions:

  • Macrophage LDL receptor expression is a key regulator of apoE secretion.
  • This interaction represents a regulatory mechanism within macrophage sterol homeostasis.
  • Findings suggest a link between macrophage lipid metabolism, apoE secretion, and atherosclerosis development.